Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.

Biotechnology

Aristea Therapeutics

Aristea Therapeutics' headquarters in San Diego, CA, United States

James Mackay

Sara McCutchan

Deanne Reid

Nihar Bhakta

Daniel O’Connell

Tyrell Rivers

Michael S. Vincent

Mark Gergen

Kenneth Harrison

Loretta Tse

Ciara Kennedy

Description

People (1)

Mark Gergen

Jobs